SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 20.98 |
Enterprise Value ($M) | 14.91 |
Book Value ($M) | 6.31 |
Book Value / Share | 0.39 |
Price / Book | 3.33 |
NCAV ($M) | 6.30 |
NCAV / Share | 0.39 |
Price / NCAV | 3.33 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -5.57 |
Return on Assets (ROA) | -0.72 |
Return on Equity (ROE) | -1.19 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.22 |
Current Ratio | 4.22 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8.26 |
Assets | 8.26 |
Liabilities | 1.96 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.01 |
Operating Income | -28.49 |
Net Income | -35.14 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -30.14 |
Cash from Investing | 1.35 |
Cash from Financing | -18.14 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | MSD Partners, L.P. | 9.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,387 | 28,360 | 19.00 | |
3,273 | 20,211 | 16.19 | |
8,618 | 46,283 | 18.62 | |
12,932 | 7,551 | 171.26 | |
(click for more detail) |
Similar Companies | |
---|---|
SXTP – 60 Degrees Pharmaceuticals, Inc. | SYBX – Synlogic, Inc. |
TCON – TRACON Pharmaceuticals, Inc. | TELO – Telomir Pharmaceuticals, Inc. |
TENX – Tenax Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io